Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway

Abstract Background Circular RNA (circRNA) is a type of stable non-coding RNA that modifies macrophage inflammation by sponging micro RNAs (miRNAs), binding to RNA-binding proteins, and undergoing translation into peptides. Activated M1 phenotype macrophages secrete matrix metalloproteinases to part...

Full description

Bibliographic Details
Main Authors: Yuhua Gao, Ningning Mi, Ying Zhang, Xiangchen Li, Weijun Guan, Chunyu Bai
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-022-01696-z
_version_ 1828127815480901632
author Yuhua Gao
Ningning Mi
Ying Zhang
Xiangchen Li
Weijun Guan
Chunyu Bai
author_facet Yuhua Gao
Ningning Mi
Ying Zhang
Xiangchen Li
Weijun Guan
Chunyu Bai
author_sort Yuhua Gao
collection DOAJ
description Abstract Background Circular RNA (circRNA) is a type of stable non-coding RNA that modifies macrophage inflammation by sponging micro RNAs (miRNAs), binding to RNA-binding proteins, and undergoing translation into peptides. Activated M1 phenotype macrophages secrete matrix metalloproteinases to participate in softening of the cervix uteri to promote vaginal delivery. Methods In this study, the premature rupture of membranes (PROM) mouse model was used to analyze the role of macrophages in this process. Profiling of circRNAs was performed using a competing endogenous RNA microarray, and their functions were elucidated in vitro. Meanwhile, adipose tissue-derived stem cell-secreted extracellular vesicles (EVs) were applied as a vehicle to transport small interfering RNAs (siRNAs) targeting the circRNAs to demonstrate their biological function in vivo. Results The miRNA miR-1931 is dependent on the nuclear factor kappa-B (NF-κB) pathway but negatively regulates its activation by targeting the NF-κB signaling transducer TRAF6 to prevent polarization of M1 macrophages and inhibit matrix metalloproteinase (MMP) secretion. The host gene of circRNA B4GALNT1, also an NF-κB pathway-dependent gene, circularizes to form circRNA_0002047, which sponges miR-1931 to maintain NF-κB pathway activation and MMP secretion in vitro. In the PROM model, EVs loaded with siRNAs targeting circRNAs demonstrated that the circRNAs reduced miR-1931 expression to maintain NF-κB pathway activation and MMP secretion for accelerating PROM in vivo. Conclusions Our data provide insights into understanding PROM pathogenesis and improving PROM treatment.
first_indexed 2024-04-11T15:56:24Z
format Article
id doaj.art-f9feafe76d4744c1bfc650c6c60acb9f
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-11T15:56:24Z
publishDate 2022-11-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-f9feafe76d4744c1bfc650c6c60acb9f2022-12-22T04:15:10ZengBMCJournal of Nanobiotechnology1477-31552022-11-0120111810.1186/s12951-022-01696-zUterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathwayYuhua Gao0Ningning Mi1Ying Zhang2Xiangchen Li3Weijun Guan4Chunyu Bai5Institute of Precision Medicine, Jining Medical UniversityInstitute of Precision Medicine, Jining Medical UniversityInstitute of Precision Medicine, Jining Medical UniversityCollege of Animal Science and Technology, College of Veterinary Medicine, Zhejiang A&F UniversityInstitute of Animal Sciences, Chinese Academy of Agricultural SciencesInstitute of Precision Medicine, Jining Medical UniversityAbstract Background Circular RNA (circRNA) is a type of stable non-coding RNA that modifies macrophage inflammation by sponging micro RNAs (miRNAs), binding to RNA-binding proteins, and undergoing translation into peptides. Activated M1 phenotype macrophages secrete matrix metalloproteinases to participate in softening of the cervix uteri to promote vaginal delivery. Methods In this study, the premature rupture of membranes (PROM) mouse model was used to analyze the role of macrophages in this process. Profiling of circRNAs was performed using a competing endogenous RNA microarray, and their functions were elucidated in vitro. Meanwhile, adipose tissue-derived stem cell-secreted extracellular vesicles (EVs) were applied as a vehicle to transport small interfering RNAs (siRNAs) targeting the circRNAs to demonstrate their biological function in vivo. Results The miRNA miR-1931 is dependent on the nuclear factor kappa-B (NF-κB) pathway but negatively regulates its activation by targeting the NF-κB signaling transducer TRAF6 to prevent polarization of M1 macrophages and inhibit matrix metalloproteinase (MMP) secretion. The host gene of circRNA B4GALNT1, also an NF-κB pathway-dependent gene, circularizes to form circRNA_0002047, which sponges miR-1931 to maintain NF-κB pathway activation and MMP secretion in vitro. In the PROM model, EVs loaded with siRNAs targeting circRNAs demonstrated that the circRNAs reduced miR-1931 expression to maintain NF-κB pathway activation and MMP secretion for accelerating PROM in vivo. Conclusions Our data provide insights into understanding PROM pathogenesis and improving PROM treatment.https://doi.org/10.1186/s12951-022-01696-zPROMMMPsMacrophagesADSCsExtracellular vesicles
spellingShingle Yuhua Gao
Ningning Mi
Ying Zhang
Xiangchen Li
Weijun Guan
Chunyu Bai
Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway
Journal of Nanobiotechnology
PROM
MMPs
Macrophages
ADSCs
Extracellular vesicles
title Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway
title_full Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway
title_fullStr Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway
title_full_unstemmed Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway
title_short Uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified ADSC-EVs through a circRNA/miRNA/NF-κB pathway
title_sort uterine macrophages as treatment targets for therapy of premature rupture of membranes by modified adsc evs through a circrna mirna nf κb pathway
topic PROM
MMPs
Macrophages
ADSCs
Extracellular vesicles
url https://doi.org/10.1186/s12951-022-01696-z
work_keys_str_mv AT yuhuagao uterinemacrophagesastreatmenttargetsfortherapyofprematureruptureofmembranesbymodifiedadscevsthroughacircrnamirnanfkbpathway
AT ningningmi uterinemacrophagesastreatmenttargetsfortherapyofprematureruptureofmembranesbymodifiedadscevsthroughacircrnamirnanfkbpathway
AT yingzhang uterinemacrophagesastreatmenttargetsfortherapyofprematureruptureofmembranesbymodifiedadscevsthroughacircrnamirnanfkbpathway
AT xiangchenli uterinemacrophagesastreatmenttargetsfortherapyofprematureruptureofmembranesbymodifiedadscevsthroughacircrnamirnanfkbpathway
AT weijunguan uterinemacrophagesastreatmenttargetsfortherapyofprematureruptureofmembranesbymodifiedadscevsthroughacircrnamirnanfkbpathway
AT chunyubai uterinemacrophagesastreatmenttargetsfortherapyofprematureruptureofmembranesbymodifiedadscevsthroughacircrnamirnanfkbpathway